These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1657206)

  • 1. [Hepatitis C].
    Lissen E; Pineda JA
    Enferm Infecc Microbiol Clin; 1991; 9(6):320-2. PubMed ID: 1657206
    [No Abstract]   [Full Text] [Related]  

  • 2. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention for hepatitis C virus transmission].
    Sekiguchi S
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serological results for hepatitis C in hemodialysis patients].
    Jordán M; Vila B; Carsi F; Martínez F; Font I
    Enferm Infecc Microbiol Clin; 1992; 10(6):382. PubMed ID: 1327172
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to hepatitis C virus in people from Yucatan, Mexico.
    Góngora-Biachi RA; González-Martínez P; Puerto FI; Yamaguchi K; Nishimura Y; Takatsuki K
    Rev Invest Clin; 1992; 44(2):284. PubMed ID: 1332170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Post-transfusion hepatitis C in Finland].
    Ebeling F
    Duodecim; 1993; 109(8):709. PubMed ID: 7520387
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 12. [The hepatitis C problem in transfusions in military medicine].
    Danil'chenko VV; Zhiburt EB; Bel'gesov NV; Serebrianaia NB; Sidorkevich SV
    Voen Med Zh; 1994 Jun; (6):44-5, 80. PubMed ID: 7941454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
    León P; Echevarría JM
    Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
    [No Abstract]   [Full Text] [Related]  

  • 14. [The prevalence of anti-HCV positivity among blood donors in Asturias. A clinical-epidemiologic study].
    Suárez A; Rodríguez M; Riestra S; Navascués CA; San Román FS; Otero L; Martínez A; Rodrigo L
    Med Clin (Barc); 1994 Nov; 103(16):606-10. PubMed ID: 7996916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
    Baur P; Roelcke D
    Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The recent incidence of post-transfusion hepatitis C since the implementation of the anti-HCV screening program for blood donors].
    Katayama T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):383-8. PubMed ID: 7563764
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral hepatitis and blood transfusion].
    Larsen J; Hetland G; Skaug K; Maeland A
    Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present status of transfusion-associated hepatitis C virus infection--efficiency after implementation of nucleic acid amplification testing].
    Takahashi M; Muraoka M; Tadokoro K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):267-71. PubMed ID: 15359805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.